Step count increase with the use o… for Parkinson's (NCT04848077)
Increase daily walking step count
- Trial ID
- NCT04848077
- Official Title
- STEPWISE Parkinson: A Smartphone Based, Titrated Exercise Solution for Patients With Parkinson's Disease in Daily Life
- Goal
- Increase daily walking step count
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Radboud University Medical Center
- Study Type
- INTERVENTIONAL
- Enrollment
- 452 participants
- Conditions
- Movement Disorders, Parkinson Disease
- Interventions
- Step count increase with the use of a motivational smartphone application
Summary For Families
The goal is to help people with Parkinson's who walk relatively little increase their daily step count to boost mobility, fitness, and everyday function. The approach uses a motivational smartphone app that tracks steps and gives personalized, gradually increased step-count targets with reminders and feedback, so it nudges more walking in daily life without changing medications like levodopa. Adults with idiopathic Parkinson's at Hoehn and Yahr stages 1 to 3 who can walk independently, understand Dutch, and currently average under 7,000 steps per day are being enrolled. People with frequent recent falls, other mobility-limiting medical problems, cognitive issues that prevent app use, those living in nursing homes, or without a compatible smartphone are excluded.
Locations
- Radboud university medical center, Nijmegen, Gelderland, Netherlands
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Step count increase with the use of a motivational smartphone application. The goal is to help people with Parkinson's who walk relatively little increase their daily step count to boost mobility, fitness, and everyday function. The approach uses a motivational smartphone app that tracks steps and gives personalized, gradually increased step-count targets with reminders and feedback, so it nudges more walking in daily life without changing medications like levodopa. Adults with idiopathic Parkinson's at Hoehn and Yahr stages 1 to 3 who can walk independently, understand Dutch, and currently average under 7,000 steps per day are being enrolled. People with frequent recent falls, other mobility-limiting medical problems, cognitive issues that prevent app use, those living in nursing homes, or without a compatible smartphone are excluded.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 5 years and 3 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- There is no placebo group. Everyone receives an active treatment; the study compares one treatment against another.